NASDAQ : NRIX
Nurix Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 27.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.96B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Nurix Therapeutics, Inc. (NRIX) reported revenue of 701.94M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year December - November; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 701.94M | 83.98M | 54.55M | 76.99M | 38.63M | 29.75M |
| Cost of Revenue | 334.07M | 316.90M | 221.63M | 189.15M | 184.50M | 116.43M |
| Gross Profit | 367.86M | -232.92M | -167.08M | -112.16M | -145.87M | -86.68M |
| Selling, General & Admin | 78.21M | 52.74M | 45.94M | 42.90M | 38.00M | 31.20M |
| Operating Expenses | 78.21M | 52.74M | 45.94M | 42.90M | 38.00M | 31.20M |
| Operating Income | 289.66M | -285.67M | -213.03M | -155.06M | -183.87M | -117.89M |
| Interest & Investment Income | 18.55M | 21.97M | 19.73M | 11.12M | 3.51M | 823.00K |
| Pretax Income | 308.21M | -263.70M | -193.30M | -143.95M | -180.36M | -117.06M |
| Income Tax Expense | 13.34M | 760.00K | 270.00K | 131.00K | ||
| Net Income | 294.88M | -264.46M | -193.57M | -143.95M | -180.36M | -117.19M |
| Net Income to Common | 294.88M | -264.46M | -193.57M | -143.95M | -180.36M | -117.19M |
| Shares Outstanding (Basic) | 106.95M | 86.67M | 67.12M | 54.34M | 48.61M | 42.90M |
| Shares Outstanding (Diluted) | 109.54M | 86.67M | 67.12M | 54.34M | 48.61M | 42.90M |
| EPS (Basic) | 2.76 | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| EPS (Diluted) | 2.69 | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| Free Cash Flow | 369.81M | -263.47M | -181.86M | -89.77M | -172.05M | -90.03M |
| Free Cash Flow Per Share | 3.38 | -3.04 | -2.71 | -1.65 | -3.54 | -2.10 |
| Gross Margin | 52.41% | -277.36% | -145.69% | -291.38% | ||
| Operating Margin | 41.27% | -340.16% | -390.52% | -201.41% | -476.01% | -396.25% |
| Profit Margin | 42.01% | -314.90% | -354.85% | -186.98% | -466.93% | -393.93% |
| Free Cash Flow Margin | 52.68% | -313.73% | -333.38% | -116.60% | -445.42% | -302.61% |
| EBITDA | 297.77M | -277.53M | -205.01M | -148.93M | -179.72M | -115.90M |
| EBITDA Margin | 42.42% | -193.45% | ||||
| D&A For EBITDA | 8.11M | 8.14M | 8.02M | 6.13M | 4.15M | 1.99M |
| EBIT | 289.66M | -285.67M | -213.03M | -155.06M | -183.87M | -117.89M |
| EBIT Margin | 41.27% | -201.41% | ||||
| Revenue as Reported | 701.94M | 83.98M | 54.55M | 76.99M | 38.63M |
Balance sheet
Fiscal year December - November; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 720.24M | 246.96M | 110.00M | 54.63M | 64.47M | 80.51M |
| Short-Term Investments | 328.01M | 345.98M | 499.59M | 233.28M | 244.67M | 215.21M |
| Cash & Short-Term Investments | 1.05B | 592.94M | 609.58M | 287.91M | 309.14M | 295.72M |
| Accounts Receivable | 20.00M | 6.00M | ||||
| Other Receivables | 2.80M | 1.50M | 1.50M | 800.00K | 1.10M | 1.10M |
| Receivables | 22.80M | 1.50M | 1.50M | 800.00K | 1.10M | 7.10M |
| Prepaid Expenses | 32.64M | 12.38M | 8.30M | 6.79M | 8.21M | 8.29M |
| Total Current Assets | 1.10B | 606.82M | 619.39M | 295.50M | 318.45M | 311.12M |
| Property, Plant & Equipment | 68.04M | 73.01M | 45.90M | 47.95M | 29.51M | 25.34M |
| Long-Term Investments | 14.83M | 7.42M | 63.88M | 137.19M | ||
| Long-Term Deferred Charges | 100.00K | 100.00K | 500.00K | 500.00K | 500.00K | |
| Other Long-Term Assets | 8.74M | 8.21M | 3.96M | 4.22M | 4.42M | 2.62M |
| Total Assets | 1.20B | 688.13M | 669.34M | 355.60M | 416.76M | 476.77M |
| Accounts Payable | 32.98M | 11.21M | 11.48M | 6.40M | 5.06M | 6.65M |
| Accrued Expenses | 48.24M | 51.70M | 34.48M | 24.19M | 20.84M | 13.81M |
| Current Portion of Leases | 3.24M | 2.82M | 8.01M | 7.49M | 5.53M | 3.85M |
| Current Income Taxes Payable | 13.95M | 1.06M | 1.24M | 30.00K | 85.00K | 75.00K |
| Current Unearned Revenue | 8.61M | 17.58M | 38.36M | 48.10M | 37.63M | 41.21M |
| Other Current Liabilities | 23.72M | 2.10M | 2.27M | 751.00K | 1.50M | 659.00K |
| Total Current Liabilities | 130.74M | 86.47M | 95.85M | 86.96M | 70.66M | 66.26M |
| Long-Term Leases | 62.09M | 52.91M | 20.29M | 23.12M | 6.43M | 9.19M |
| Long-Term Unearned Revenue | 10.78M | 10.01M | 26.21M | 45.02M | 35.97M | 59.02M |
| Other Long-Term Liabilities | 23.38M | |||||
| Total Liabilities | 226.99M | 149.39M | 142.35M | 155.10M | 113.06M | 134.47M |
| Common Stock | 109.00K | 102.00K | 76.00K | 49.00K | 47.00K | 45.00K |
| Additional Paid-In Capital | 1.60B | 1.54B | 1.27B | 746.30M | 709.22M | 563.76M |
| Retained Earnings | -630.13M | -1.00B | -738.77M | -545.20M | -401.25M | -220.89M |
| Comprehensive Income & Other | -210.00K | 105.00K | 150.00K | -655.00K | -4.32M | -608.00K |
| Total Common Equity | 968.31M | 538.75M | 526.99M | 200.49M | 303.70M | 342.30M |
| Shareholders' Equity | 968.31M | 538.75M | 526.99M | 200.49M | 303.70M | 342.30M |
| Total Liabilities & Equity | 1.20B | 688.13M | 669.34M | 355.60M | 416.76M | 476.77M |
| Total Debt | 65.33M | 55.73M | 28.30M | 30.61M | 11.96M | 13.04M |
| Net Cash (Debt) | 982.92M | 537.21M | 581.28M | 264.71M | 361.06M | 419.87M |
| Net Cash Per Share | 8.97 | 6.20 | 8.66 | 4.87 | 7.43 | 9.79 |
| Filing Date Shares Outstanding | 109.25M | 102.84M | 75.89M | 48.89M | 47.27M | 44.74M |
| Total Common Shares Outstanding | 109.20M | 101.81M | 75.87M | 48.72M | 47.17M | 44.66M |
| Working Capital | 972.95M | 520.35M | 523.53M | 208.54M | 247.79M | 244.86M |
| Book Value Per Share | 8.87 | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 |
| Tangible Book Value | 968.31M | 538.75M | 526.99M | 200.49M | 303.70M | 342.30M |
| Tangible Book Value Per Share | 8.87 | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 |
| Machinery | 45.85M | 44.75M | 41.04M | 33.83M | 27.62M | 19.30M |
| Leasehold Improvements | 10.86M | 9.37M | 5.14M | 3.24M | 3.83M | 3.08M |
Cash flow statement
Fiscal year December - November; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 294.88M | -264.46M | -193.57M | -143.95M | -180.36M | -117.19M |
| Depreciation & Amortization | 15.27M | 18.26M | 15.13M | 12.25M | 9.61M | 5.28M |
| Other Amortization | 600.00K | 600.00K | 1.30M | 1.40M | 1.20M | 800.00K |
| Loss (Gain) From Sale of Assets | 249.00K | 89.00K | 31.00K | 556.00K | 9.00K | 128.00K |
| Loss (Gain) From Sale of Investments | -6.34M | -10.32M | -11.29M | -5.42M | 426.00K | 1.71M |
| Stock-Based Compensation | 40.66M | 37.97M | 33.93M | 33.67M | 28.13M | 15.80M |
| Other Operating Activities | 286.00K | 201.00K | ||||
| Change in Accounts Receivable | -20.00M | 6.00M | -6.00M | |||
| Change in Accounts Payable | 25.05M | -630.00K | 5.21M | 1.61M | 85.00K | 1.59M |
| Change in Unearned Revenue | -21.78M | -36.98M | -28.55M | 19.51M | -26.63M | 14.25M |
| Change in Income Taxes | 3.64M | |||||
| Change in Other Net Operating Assets | 50.73M | 6.01M | 4.94M | -1.01M | 1.52M | -4.37M |
| Operating Cash Flow | 379.31M | -249.47M | -172.58M | -81.36M | -159.81M | -84.36M |
| Capital Expenditures | -9.50M | -14.00M | -9.27M | -8.40M | -12.24M | -5.66M |
| Investment in Securities | 10.60M | 161.85M | -248.44M | 76.70M | 39.44M | -102.59M |
| Investing Cash Flow | 1.10M | 147.85M | -257.71M | 68.30M | 27.20M | -108.25M |
| Issuance of Common Stock | 261.21M | 238.64M | 485.68M | 3.22M | 22.43M | 164.13M |
| Repurchase of Common Stock | -15.00K | |||||
| Other Financing Activities | 94.76M | -10.24M | ||||
| Financing Cash Flow | 261.21M | 238.64M | 485.67M | 3.22M | 117.19M | 153.88M |
| Net Cash Flow | 641.62M | 137.03M | 55.37M | -9.85M | -15.42M | -38.73M |
| Free Cash Flow | 369.81M | -263.47M | -181.86M | -89.77M | -172.05M | -90.03M |
| Free Cash Flow Margin | 52.68% | -313.73% | -333.38% | -116.60% | -445.42% | -302.61% |
| Free Cash Flow Per Share | 3.38 | -3.04 | -2.71 | -1.65 | -3.54 | -2.10 |
| Levered Free Cash Flow | 233.34M | -143.99M | -85.90M | -41.93M | -79.42M | -37.70M |
| Unlevered Free Cash Flow | 233.34M | -143.99M | -85.90M | -41.93M | -79.42M | -37.70M |
| Cash Income Tax Paid | 481.00K | |||||
| Change in Working Capital | 34.00M | -31.60M | -18.40M | 20.12M | -19.02M | 9.11M |
Ratios
Fiscal year December - November; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.93B | 1.79B | 1.57B | 301.69M | 584.16M | 1.29B |
| Enterprise Value | 1.94B | 1.42B | 1.14B | 40.96M | 183.80M | 941.84M |
| Last Close Price | 26.80 | 17.68 | 22.11 | 6.22 | 12.39 | 28.82 |
| PS Ratio | 4.17 | 21.34 | 28.71 | 3.92 | 15.12 | 43.22 |
| PB Ratio | 3.02 | 3.33 | 2.97 | 1.50 | 1.92 | 3.76 |
| P/TBV Ratio | 3.02 | 3.33 | 2.97 | 1.50 | 1.92 | 3.76 |
| EV/Sales Ratio | 2.77 | 16.91 | 20.82 | 0.53 | 4.76 | 31.66 |
| Debt / Equity Ratio | 0.07 | 0.10 | 0.05 | 0.15 | 0.04 | 0.04 |
| Debt / FCF Ratio | 0.18 | |||||
| Net Debt / Equity Ratio | -1.01 | -1.00 | -1.10 | -1.32 | -1.19 | -1.23 |
| Net Debt / EBITDA Ratio | -3.30 | 1.94 | 2.83 | 1.78 | 2.01 | 3.62 |
| Net Debt / FCF Ratio | -2.66 | 2.04 | 3.20 | 2.95 | 2.10 | 4.66 |
| Asset Turnover | 0.82 | 0.12 | 0.11 | 0.20 | 0.09 | 0.07 |
| Quick Ratio | 8.19 | 6.87 | 6.38 | 3.32 | 4.39 | 4.57 |
| Current Ratio | 8.44 | 7.02 | 6.46 | 3.40 | 4.51 | 4.70 |
| Return on Equity (ROE) | 43.99% | -49.63% | -53.22% | -57.10% | -55.84% | -37.05% |
| Return on Assets (ROA) | 21.08% | -26.30% | -25.98% | -25.10% | -25.72% | -16.88% |
| Return on Capital Employed (ROCE) | 27.20% | -47.50% | -37.10% | -57.70% | -53.10% | -28.70% |
| Earnings Yield | 10.03% | -14.76% | -12.36% | -47.71% | -30.88% | -9.12% |
| FCF Yield | 12.63% | -14.70% | -11.61% | -29.75% | -29.45% | -7.00% |
| Buyback Yield / Dilution | -32.80% | -29.12% | -23.52% | -11.79% | -13.32% | -173.68% |